Liver X receptor protects against liver injury in sepsis caused by rodent cecal ligation and puncture

Surgical Infections

Volumn 12, Issue 4, 2011, Pages 283-289

  Wang, Yun Yong ^a   Ryg, Una ^a   Dahle, Maria K ^a,b   Steffensen, Knut R ^c,d   Thiemermann, Christoph ^e   Chaudry, Irshad H ^f   Reinholt, Finn P ^a   Collins, Jon L ^g   Nebb, Hilde I ^b   Aasen, Ansgar O ^a   Gustafsson, Jan Å ^c,d   Wang, Jacob E ^a,h  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d University of Houston   (United States)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^g GLAXOSMITHKLINE   (United States)

^h Norges forskningsrad   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ALANINE AMINOTRANSFERASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; HIGH MOBILITY GROUP B1 PROTEIN; LIVER X RECEPTOR; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CECUM; CONTROLLED STUDY; HISTOPATHOLOGY; INFLAMMATION; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; PERITONITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUNCTURE; QUANTITATIVE ANALYSIS; RAT; SEPSIS; SHAM PROCEDURE;

ANIMALS; CECUM; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; LIGATION; LIVER FAILURE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORPHAN NUCLEAR RECEPTORS; PUNCTURES; RATS; RATS, WISTAR; RODENT DISEASES; SEPSIS;

EID: 80051981704     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2010.066     Document Type: Article

References (32)

1. Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 2007;35:2408-2416. (Pubitemid 47476242)
2. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310. (Pubitemid 32641789)
3. Moreno R, Vincent JL, Matos R, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care: Results of a prospective, multicentre study. Working Group on Sepsis Related Problems of the ESICM. Intensive Care Med 1999;25:686-696. (Pubitemid 29376122)
4. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-251. (Pubitemid 29329996)
5. Alberti S, Steffensen KR, Gustafsson JA. Structural characterisation of the mouse nuclear oxysterol receptor genes LXR alpha and LXR beta. Gene 2000;243:93-103. (Pubitemid 30079709)
6. Janowski BA, Willy PJ, Devi TR, et al. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996;383:728-731. (Pubitemid 26360651)
7. Peet DJ, Turley SD, Ma WZ, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998;93:693-704. (Pubitemid 28257577)
8. Schuster GU, Johansson L, Kietz S, et al. Improved metabolic control by depletion of liver X receptors in mice. Biochem Biophys Res Commun 2006;348:176-182. (Pubitemid 44177675)
9. Repa JJ, Mangelsdorf DJ. The liver X receptor gene team: Potential new players in atherosclerosis. Nat Med 2002;8: 1243-1248. (Pubitemid 35373555)
10. Repa JJ, Berge KE, Pomajzl C, et al. Regulation of ATPbinding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 2002;277: 18793-18800. (Pubitemid 34952438)
11. Laffitte BA, Chao LC, Li J, et al. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sc USA 2003;100:5419-5424. (Pubitemid 36542720)
12. Albers M, Blume B, Schlueter T, et al. A novel principle for partial agonism of liver X receptor ligands: Competitive recruitment of activators and repressors. J Biol Chem 2006;281: 4920-4930. (Pubitemid 43847754)
13. Castrillo A, Joseph SB, Marathe C, et al. Liver X receptordependent repression of matrix metalloproteinase-9 expression in macrophages. J Biol Chem 2003;278:10443-10449. (Pubitemid 36800310)
14. Joseph SB, Castrillo A, Laffitte BA, et al. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 2003;9:213-219. (Pubitemid 36227724)
15. Venteclef N, Jakobsson T, Ehrlund A, et al. GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response. Genes Dev 2010;24:381-395.
16. Joseph SB, Bradley MN, Castrillo A, et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 2004;119:299-309. (Pubitemid 39360910)
17. Valledor AF, Hsu LC, Ogawa S, et al. Activation of liver X receptors and retinoid X receptors prevents bacterialinduced macrophage apoptosis. Proc Natl Acad Sci USA 2004;101:17813-17818. (Pubitemid 40051969)
18. Korf H, Vander BS, Romano M, et al. Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice. J Clin Invest 2009;119:1626-1637.
19. Xu J, Wagoner G, Douglas JC, et al. Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity. J Leukoc Biol 2009;86:401-409.
20. Gupta DS, Kaul D, Kanwar AJ, et al. Psoriasis: Crucial role of LXR-alpha RNomics. Genes Immun 2010;11:37-44.
21. Park MC, Kwon YJ, Chung SJ, et al. Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice. Rheumatology 2010;49:882-890.
22. Wang YY, Dahle MK, Steffensen KR, et al. Liver X receptor agonist GW3965 dose-dependently regulates LPS-mediated liver injury and modulates posttranscriptional TNF-alpha production and p38 mitogen-activated protein kinase activation in liver macrophages. Shock 2009;32:548-553.
23. Wang YY, Dahle MK, Agren J, et al. Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation. Shock 2006;25:141-146.
24. Collins JL, Fivush AM, Watson MA, et al. Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem 2002;45:1963-1966. (Pubitemid 34477709)
25. Chaudry IH, Wichterman KA, Baue AE. Effect of sepsis on tissue adenine nucleotide levels. Surgery 1979;85:205-211. (Pubitemid 9097866)
26. Baker CC, Chaudry IH, Gaines HO, et al. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983;94:331-335. (Pubitemid 13043132)
27. Bernard GR, Macias WL, Joyce DE, et al. Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis. Crit Care 2003;7:155-163. (Pubitemid 36432674)
28. Panacek EA, Marshall JC, Albertson TE, et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab0)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 2004;32: 2173-2182. (Pubitemid 39491795)
29. Dalen KT, Ulven SM, Bamberg K, et al. Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha. J Biol Chem 2003; 278:48283-48291. (Pubitemid 37526713)
30. Gong H, He J, Lee JH, et al. Activation of the liver X receptor prevents lipopolysaccharide-induced lung injury. J Biol Chem 2009;284:30113-30121.
31. Myhre AE, Agren J, Dahle MK, et al. Liver X receptor is a key regulator of cytokine release in human monocytes. Shock 2008;29:468-474. (Pubitemid 351416800)
32. Yang H, Ochani M, Li J, et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004;101:296-301. (Pubitemid 38084244)